About Verscend
Verscend is a company based in Waltham (United States) founded in 1996 was acquired by Veritas Capital in April 2016. Verscend has raised $15 million across 1 funding round from investors including Veritas Capital and ISO. Verscend has completed 2 acquisitions, including Cotiviti and HealthCare Insight. Verscend offers products and services including Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement. Verscend operates in a competitive market with competitors including Ribbon Health, Prognos Health, PurpleLab, Madaket Health and PrecisionGx, among others.
- Headquarter Waltham, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cotiviti, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Jul 16, 2006
-
Investors
Veritas Capital
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Cotiviti
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Verscend
Verscend offers a comprehensive portfolio of products and services, including Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement.
Tools for accurate claim validation and payment integrity.
Solutions for ensuring proper reimbursement through data analysis.
Services to improve clinical and financial performance metrics.
Platforms for driving member actions and health outcomes.
Funding Insights of Verscend
Verscend has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in July 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Verscend
Verscend has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Veritas Capital and ISO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology enterprises are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
International standards are developed and coordinated worldwide.
|
Locked | Locked | Locked |
Investor details for Verscend
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verscend
Verscend has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cotiviti and HealthCare Insight.
Investment portfolio details for Verscend
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
SaaS software detects and prevents healthcare fraud, abuse, and overpayments.
|
Locked | Locked | 1997 | Locked | |
|
Analytics-driven payment accuracy solutions for healthcare payers are provided.
|
Locked | Locked | 1979 | Locked |
Complete acquisition details for Verscend
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Verscend
Detailed financials for Verscend
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verscend Comparisons
Peer comparison for Verscend
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Verscend
Verscend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ribbon Health, Prognos Health, PurpleLab, Madaket Health and PrecisionGx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Predictive analytics platform is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
AI-based platform for clinical data sharing and management is provided.
|
|
| Locked | Locked | Locked |
Healthcare analytics solutions for healthcare stakeholders
|
|
| Locked | Locked | Locked |
Data management software is provided for healthcare administration tasks.
|
|
| Locked | Locked | Locked |
AI-based health plan analytics solutions for health insurers
|
|
| Locked | Locked | Locked |
Cloud-based cost containment solutions are delivered to healthcare providers.
|
Detailed competitors of Verscend
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verscend
Complete news archive for Verscend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verscend
Verscend was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Verscend is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Emad Rizk is the current CEO of Verscend.
Verscend is a funded company, having raised a total of $15M across 1 funding round to date.
Verscend was founded in 1996 and is based in Waltham, United States. Healthcare data analytics solutions are offered, including population health analytics with DxCG Intelligence for risk adjustment and predictive modeling. Payment accuracy services encompass cost containment, online fraud monitoring, Medicare and commercial risk adjustment, and quality improvement for HEDIS compliance. Medical record retrieval and abstraction solutions are also provided to support payers.
Verscend's top competitors include Ribbon Health, Prognos Health and PurpleLab.
Verscend offers Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement.
Verscend has made 2 acquisitions, including Cotiviti, and HealthCare Insight.
Verscend has 2 investors. Key investors include Veritas Capital, and ISO.